M.C. Garassino

Discipline

Economies et finances (1)

Type de document

Articles (10) Recensions (4)

Co-auteur

Date

Source

Mot-clé

Human beings (7) Cancer (7) Pneumonia (6) maladie (6) oncologie (5) mortalité (5) maladie (5) cancer (5) Mortality (5) Treatment (5) Cancer (5) Patients (5) Oncology (5) Mortality (5) Impact (5) Cancer--Patients (5) Patients (5) société (humaine) (4) risque (4) Care (4) Risk (4) Management (4) Lungs (4) Evidence (4) Population (4) Practice (4) temps (durée) (3) tabagisme (3) recherche (3) épuration (3)

Documents écrit par M.C. Garassino (10) | parle de M.C. Garassino (0)

Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study.
N. Girard et al.
Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey.
P. Garrido et al.
Severity of COVID-19 in patients with lung cancer: evidence and challenges.
A. Passaro et al.
Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience.
A. Trama et al. (9 nov. 2020)
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus.
G. Curigliano et al.
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
M.C. Garassino et al.
Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic.
A.C. Dingemans et al.
TERAVOLT: Thoracic Cancers International COVID-19 Collaboration.
J.G. Whisenant et al. (8 juin 2020)
Report on the status of women occupying leadership roles in oncology.
E. Hofstädter-Thalmann et al. (2018)
Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey.
S. Banerjee et al. (2018)